3 Steps To Improve Site Acceptance of ePRO in Medical Device Trials
Medical device organizations aim to reduce development time by 25% in the next five years. The adoption of ePRO can help make this goal a reality.
Medical device organizations aim to reduce development time by 25% in the next five years. The adoption of ePRO can help make this goal a reality.
Global medical device maker Nevro successfully integrates Medrio EDC and ePRO to transition from paper to digital data collection.
The use of multimedia, including videos, animations, or interactive graphics in clinical trials is growing. Although its impact on the success of clinical trials is not yet fully understood, studies have shown that it can improve participant engagement, comprehension, and retention of study information.
Healthcare reimbursement is starting to use patient-reported outcomes as proof that a drug or treatment improves the quality of life enough to warrant the cost.
CROs face growing pressure to differentiate themselves. Myths about sponsor expectations and priorities surrounding eClinical technology can cause CROs to lose bids.
When engaging CROs, sponsors are increasingly prioritizing performance excellence and replicable operating standards.
Protocol amendments are inevitable, but choosing the right RTSM partner can help you navigate study changes with speed and agility.
Medrio, a global leader in eClinical software and services used in decentralized, hybrid, and traditional clinical trials, is pleased to announce it received a Silver Award at the 2022 Davey Awards for its “Build It Better: ePRO Accreditation Program.”
With increasing regulatory requirements for the inclusion of patient-reported outcomes in study data, maintaining the status quo in PRO collection can have costly consequences.
Participant education is a critical part of informed consent and one that is easy to improve by leveraging established patient education best practices. Medrio CEO Nicole Latimer discusses some of the most successful approaches she has seen in her career:
Does your CRO or sponsor have a policy around IP numbering in clinical trials? If not, they could be putting your clinical trial at risk.
San Francisco, CA (August 19, 2022) — Medrio, a global leader in eClinical software and services used in decentralized, hybrid, and traditional clinical trials, has successfully completed a System and Organization Controls (SOC) 2 Type 2 examination. The independent third-party report attests to the controls at Medrio regarding the security, availability, and confidentiality of its eClinical technology and solutions.
Sign up to have our the latest insights delivered to your inbox.